Nilabha Mukherjea

Nilabha Mukherjea

Auto-generated profile, based on publicly available information

Nilabha Mukherjea

Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA 14850, United States of America

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in ECS Journal of Solid State Science and Technology
Verified
Journal Article
Open access
NMNilabha Mukherjea
Nilabha Mukherjea
RRRuhi Ranjan
Ruhi Ranjan
WLWenxuan (Evelyn) Li
Wenxuan (Evelyn) Li
SDSandeep Darar
Sandeep Darar
SMSamantha Makmur
Samantha Makmur
PBPreetam Bhardwaj
Preetam Bhardwaj
Black phosphorus nanomaterials (BPN), including 2D phosphorene, 1D nanoribbons, and 0D BP quantum dots (BPQDs) exhibit superior electronic performance, remarkable biocompatibility, and tunable bandgap energy. They present immense potential in a variety of fields involving electronics, energy storage, biosensing, and biomedical applications. Despite these favorable characteristics, there are some significant obstacles impeding the widespread adoption of BPN, which includes their degradation in moisture, light, and oxygen-rich environments, difficulties in achieving scalable, high-quality BPN production and instability in electrocatalysis further limit their practical applications. Future work will revolve around optimizing BPN synthesis, thoroughly examining the degradation mechanisms, maintaining BPN stability, and comprehending the biosafety of BP analogues and polymers. In particular, the review suggests exploring BP-metal/metal oxide nanostructure composites, as well as conducting additional research on BPQD-based nanocomposites for biological imaging and drug delivery. Development of efficient anti-degradation strategies, advancement of synthesis techniques, and a deeper understanding of the characteristics and potential applications of BPN will unlock their immense potential across various fields.

1 May 2023 in Journal of the Electrochemical Society
Verified
Journal Article
Open access
ABAnusuiya Bora
Anusuiya Bora
RSRashi Sharma
Rashi Sharma
IGIshi Gupta
Ishi Gupta
MSMahika Singh
Mahika Singh
NMNilabha Mukherjea
Nilabha Mukherjea
ACArghya Chakravorty
Arghya Chakravorty
Today, cancer is analyzed after it has metastasized throughout the body. This understanding demands earlier identification of cancer to enable better opportunities for a cure. Viable and well-defined strategies to discover cancer and clinical determination are the need of the hour. Biosensors are devices intended to recognize a particular natural analyte by recognizing an organic element (i.e., protein, DNA, RNA) to produce the signals as an electrical signature that can be distinguished and investigated. The utilization of biosensors in disease recognition and observation holds immense potential in diagnosis and treatment. Biosensors can detect cancer biomarkers and decide drug adequacy at different objective destinations. Innovations attributed to biosensors can give a quick and exact location, dependable imaging of cancer cells, observe angiogenesis and disease metastasis, and have the capacity to decide the adequacy of anticancer chemotherapy for specialists. This review briefly summarizes the growing utilization of magneto-electrochemical biosensors as indicative devices and some of its future uses of biosensor innovation.